TFGT
ABBV icon

TS Financial Group (TSFG)’s AbbVie ABBV Stock Holding History

TS Financial Group (TSFG)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8M Buy
134,486
+6,734
+5% +$1.45M 4.26% 4
2026
Q1 		$27.8M Buy
127,752
+3,205
+3% +$711K 4.22% 5
2025
Q4 		$28.5M Buy
124,547
+1,115
+0.9% +$254K 4.25% 5
2025
Q3 		$28.6M Buy
123,432
+3,250
+3% +$662K 4.54% 4
2025
Q2 		$22.3M Buy
120,182
+3,802
+3% +$707K 4.04% 3
2025
Q1 		$24.4M Buy
116,380
+1,826
+2% +$355K 4.99% 4
2024
Q4 		$20.4M Buy
114,554
+9,866
+9% +$1.81M 4.18% 4
2024
Q3 		$20.7M Sell
104,688
-1,632
-2% -$305K 4.51% 4
2024
Q2 		$18.2M Sell
106,320
-177
-0.2% -$29.3K 4.26% 4
2024
Q1 		$19.4M Sell
106,497
-18,924
-15% -$3.26M 4.89% 4
2023
Q4 		$19.4M Sell
125,421
-2,544
-2% -$371K 6.13% 3
2023
Q3 		$19.1M Buy
127,965
+3,324
+3% +$488K 6.8% 2
2023
Q2 		$16.8M Buy
124,641
+932
+0.8% +$137K 6.26% 2
2023
Q1 		$19.7M Sell
123,709
-1,682
-1% -$257K 7.31% 1
2022
Q4 		$20.3M Buy
125,391
+4,670
+4% +$716K 8.05% 1
2022
Q3 		$16.2M Buy
120,721
+6,298
+6% +$904K 7.59% 2
2022
Q2 		$17.5M Sell
114,423
-4,882
-4% -$746K 7.53% 1
2022
Q1 		$19.3M Sell
119,305
-2,716
-2% -$395K 7.01% 2
2021
Q4 		$16.5M Buy
122,021
+11,958
+11% +$1.41M 5.75% 3
2021
Q3 		$11.9M Buy
110,063
+6,446
+6% +$737K 4.63% 3
2021
Q2 		$11.7M Buy
103,617
+3,023
+3% +$340K 4.7% 3
2021
Q1 		$10.9M Buy
100,594
+3,189
+3% +$341K 5.53% 3
2020
Q4 		$10.4M Sell
97,405
-1,538
-2% -$148K 5.58% 3
2020
Q3 		$8.67M Buy
98,943
+13,478
+16% +$1.27M 5.15% 4
2020
Q2 		$8.39M Buy
85,465
+11,946
+16% +$1.05M 5.54% 3
2020
Q1 		$5.6M Sell
73,519
-173
-0.2% -$14.7K 5% 5
2019
Q4 		$6.53M Buy
73,692
+8,731
+13% +$725K 4.83% 5
2019
Q3 		$4.92M Buy
64,961
+12,659
+24% +$868K 3.77% 7
2019
Q2 		$3.8M Buy
52,302
+13,268
+34% +$1.04M 3.05% 8
2019
Q1 		$3.15M Buy
+39,034
New +$3.19M 2.68% 9

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

TS Financial Group (TSFG)'s ABBV Position: Q2 2026 in Review

TS Financial Group (TSFG) increased its AbbVie (ABBV) stake by 5.3% in Q2 2026, buying an estimated $1.45M and bringing the position to 134,486 shares worth $33.8M. The position accounts for 4.26% of the portfolio, ranked #4.

TS Financial Group (TSFG) first reported a position in ABBV in Q1 2019 and has held it in 30 quarters since. 1,743 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TS Financial Group (TSFG) held 134,486 shares of AbbVie worth $33.8M as of Q2 2026.
  • TS Financial Group (TSFG) bought 6,734 AbbVie shares in Q2 2026, an estimated $1.45M.
  • AbbVie made up 4.26% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #4 holding.
  • TS Financial Group (TSFG) first reported a position in AbbVie in Q1 2019 and has held it in 30 quarters since.
  • 1,743 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.